APA (7th ed.) Citation

H, Z., Y, L., B, W., & D, C. (2020). Cost-effectiveness of omalizumab for the treatment of inadequately controlled severe allergic asthma in Chinese children. The Journal of asthma : official journal of the Association for the Care of Asthma, 57(1), 87. https://doi.org/10.1080/02770903.2018.1544642

Chicago Style (17th ed.) Citation

H, Zhou, Lu Y, Wu B, and Che D. "Cost-effectiveness of Omalizumab for the Treatment of Inadequately Controlled Severe Allergic Asthma in Chinese Children." The Journal of Asthma : Official Journal of the Association for the Care of Asthma 57, no. 1 (2020): 87. https://doi.org/10.1080/02770903.2018.1544642.

MLA (9th ed.) Citation

H, Zhou, et al. "Cost-effectiveness of Omalizumab for the Treatment of Inadequately Controlled Severe Allergic Asthma in Chinese Children." The Journal of Asthma : Official Journal of the Association for the Care of Asthma, vol. 57, no. 1, 2020, p. 87, https://doi.org/10.1080/02770903.2018.1544642.